WO2008003748A3 - Cd300lg polypeptides and their use in treating autoimmune diseases - Google Patents
Cd300lg polypeptides and their use in treating autoimmune diseases Download PDFInfo
- Publication number
- WO2008003748A3 WO2008003748A3 PCT/EP2007/056815 EP2007056815W WO2008003748A3 WO 2008003748 A3 WO2008003748 A3 WO 2008003748A3 EP 2007056815 W EP2007056815 W EP 2007056815W WO 2008003748 A3 WO2008003748 A3 WO 2008003748A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cd300lg
- polypeptides
- autoimmune diseases
- treating autoimmune
- disorders
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pulmonology (AREA)
- Transplantation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The present invention relatates to novel CD300LG polypeptides, more specifically soluble forms thereof and provides use thereof and methods for preventing and/or treating diseases and/or disorders such as inflammatory diseases, including various inflammatory autoimmune disorders, allergic hypersensitivity, allograft rejection and/or syndromes associated with increased CD300LG-FL polypeptide function on dendritic cells.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06116778 | 2006-07-07 | ||
EP06116778.9 | 2006-07-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008003748A2 WO2008003748A2 (en) | 2008-01-10 |
WO2008003748A3 true WO2008003748A3 (en) | 2008-04-17 |
Family
ID=37027862
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2007/056815 WO2008003748A2 (en) | 2006-07-07 | 2007-07-05 | Cd300lg polypeptides and their use in treating autoimmune diseases |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2008003748A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101233073B1 (en) | 2011-01-13 | 2013-02-14 | 강원대학교산학협력단 | Pharmaceutical composition comprising peptide having inhibitory activities against transendothelial migration of leucocytes and metastasis of cancer cells |
KR101291764B1 (en) | 2011-03-04 | 2013-08-01 | 경북대학교 산학협력단 | CD300a synthetic peptides and compositions for regulation of immune response comprising thereof |
EP3412770A4 (en) * | 2016-02-03 | 2019-08-07 | Japan as represented by Director General of Agency of National Institute of Infectious Deseases | Cultured transgenic cell allowing growth of norovirus, and use thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999046281A2 (en) * | 1998-03-10 | 1999-09-16 | Genentech, Inc. | Novel polypeptides and nucleic acids encoding the same |
WO2003080667A2 (en) * | 2002-03-22 | 2003-10-02 | Bioxell S.P.A. | A novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof |
US20030194704A1 (en) * | 2002-04-03 | 2003-10-16 | Penn Sharron Gaynor | Human genome-derived single exon nucleic acid probes useful for gene expression analysis two |
WO2005056597A1 (en) * | 2003-12-09 | 2005-06-23 | Riken | IMMUNOGLOBULIN Fc RECEPTOR PROTEIN |
-
2007
- 2007-07-05 WO PCT/EP2007/056815 patent/WO2008003748A2/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999046281A2 (en) * | 1998-03-10 | 1999-09-16 | Genentech, Inc. | Novel polypeptides and nucleic acids encoding the same |
WO2003080667A2 (en) * | 2002-03-22 | 2003-10-02 | Bioxell S.P.A. | A novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof |
US20030194704A1 (en) * | 2002-04-03 | 2003-10-16 | Penn Sharron Gaynor | Human genome-derived single exon nucleic acid probes useful for gene expression analysis two |
WO2005056597A1 (en) * | 2003-12-09 | 2005-06-23 | Riken | IMMUNOGLOBULIN Fc RECEPTOR PROTEIN |
Non-Patent Citations (12)
Title |
---|
CARSON M J ET AL: "Differential expression of the triggering receptors expressed on myeloid cells (TREMs) family of receptors by CNS microglia and PE", JOURNAL OF NEUROCHEMISTRY, NEW YORK, NY, US, vol. 96, no. suppl 1, March 2006 (2006-03-01), pages 37, XP009096349, ISSN: 0022-3042 * |
CHUNG D-H ET AL: "CMRF-35-like-molecular-1, a novel mouse myeloid receptor, can inhibit osteoclast formation", JOURNAL OF IMMUNOLOGY, THE WILLIAMS AND WILKINS CO. BALTIMORE, US, vol. 171, 2003, pages 6541 - 6548, XP002997904, ISSN: 0022-1767 * |
DATABASE Geneseq [online] 20 January 2003 (2003-01-20), "Human polypeptide SEQ ID NO 1170.", XP002470025, retrieved from EBI accession no. GSP:ABP69123 Database accession no. ABP69123 * |
DATABASE Geneseq [online] 22 September 2005 (2005-09-22), "Cancer cell diagnosis method-related human protein - SEQ ID 386.", XP002409457, retrieved from EBI accession no. GSN:AEB14103 Database accession no. AEB14103 * |
DATABASE Geneseq [online] 25 August 2005 (2005-08-25), "Human h-eIgR-L.", XP002409456, retrieved from EBI accession no. GSN:AEA49996 Database accession no. AEA49996 * |
DATABASE Geneseq [online] 25 August 2005 (2005-08-25), "Human h-eIgR-Salpha.", XP002470023, retrieved from EBI accession no. GSP:AEA50000 Database accession no. AEA50000 * |
DATABASE Geneseq [online] 25 August 2005 (2005-08-25), "Human h-eIgR-Sbeta.", XP002470024, retrieved from EBI accession no. GSP:AEA50002 Database accession no. AEA50002 * |
DATABASE Geneseq [online] 29 July 2004 (2004-07-29), "Human genome derived single exon protein #682.", XP002409455, retrieved from EBI accession no. GSN:ABO54448 Database accession no. ABO54448 * |
DATABASE Geneseq [online] 4 December 2003 (2003-12-04), "Human immune response associated protein IRAP-6 SEQ ID NO:6.", XP002470026, retrieved from EBI accession no. GSP:ADB36335 Database accession no. ADB36335 * |
TAKATSU ET AL: "CD300 antigen like family member G: A novel Ig receptor like protein exclusively expressed on capillary endothelium", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, vol. 348, no. 1, 15 September 2006 (2006-09-15), pages 183 - 191, XP005593049, ISSN: 0006-291X * |
UMEMOTO EIJI ET AL: "Nepmucin, a novel HEV sialomucin, mediates L-selectin-dependent lymphocyte rolling and promotes lymphocyte adhesion under flow.", THE JOURNAL OF EXPERIMENTAL MEDICINE 12 JUN 2006, vol. 203, no. 6, 12 June 2006 (2006-06-12), pages 1603 - 1614, XP002470021, ISSN: 0022-1007 * |
VIERTLBOECK B C ET AL: "The chicken immunoregulatory receptor families SIRP, TREM, and CMRF35/CD300L", IMMUNOGENETICS 2006 GERMANY, vol. 58, no. 2-3, February 2006 (2006-02-01), pages 180 - 190, XP002470022, ISSN: 0093-7711 * |
Also Published As
Publication number | Publication date |
---|---|
WO2008003748A2 (en) | 2008-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006003388A8 (en) | Compositions and methods for treating inflammatory disorders | |
WO2006122222A3 (en) | Shape tunable plasmonic nanoparticles | |
WO2010011944A3 (en) | Protein screeing methods | |
WO2007126439A3 (en) | Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling involving antibodies that bind to il-22 and il-22r | |
WO2007061874A3 (en) | Methods and compositions for use in treating cancer | |
WO2006070286A3 (en) | Monoclonal antibodies against nkg2a | |
WO2009007849A3 (en) | Il-23 receptor antagonists and uses thereof | |
WO2006026570A3 (en) | Use of stem cells to generate inner ear cells | |
MX2009006651A (en) | Activin-actrii antagonists and uses for increasing red blood cell levels. | |
WO2006068987A3 (en) | Uses of il-23 antagonists in the treatment of diabetes mellitus | |
WO2006130580A3 (en) | Mutant il-10 | |
WO2006132969A3 (en) | Incorporation of non-naturally encoded amino acids into proteins | |
WO2008106429A3 (en) | Methods and compositions for the treatment of heart failure and other disorders | |
WO2009158015A3 (en) | Antagonists of actriib and uses for increasing red blood cell levels | |
WO2007106769A3 (en) | Antibodies that bind both il-17a and il-17f and methods of using the same | |
EP2447280A3 (en) | VEGF analogs and methods of use | |
WO2008011392A8 (en) | Proline urea ccr1 antagonists for the treatment of autoimmune diseases or inflammation | |
WO2006096489A3 (en) | Anti-m-csf antibody compositions having reduced levels of endotoxin | |
WO2004085475A3 (en) | Anti-il-20 antibodies and binding partners and methods of using in inflammation | |
WO2007006307A3 (en) | Novel salts of fumaric acid monoalkylesters and their pharmaceutical use | |
WO2008115719A9 (en) | Fused amino pyridine as hsp90 inhibitors | |
WO2009095489A3 (en) | Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of diseases and disorders associated with il-6-mediated signalling | |
WO2010009478A3 (en) | Compositions and methods for treating disorders associated with overweight animals | |
WO2007068750A3 (en) | Immunoglobulins directed against nogo | |
WO2008066630A3 (en) | Methods for reprogramming adult somatic cells and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07787106 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07787106 Country of ref document: EP Kind code of ref document: A2 |